Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.

Activation of the kappa opioid receptor (KOR) contributes to the aversive properties of stress, and modulates key neuronal circuits underlying many neurobehavioral disorders. KOR agonists directly inhibit ventral tegmental area (VTA) dopaminergic neurons, contributing to aversive responses (Margolis...

Full description

Bibliographic Details
Main Authors: Elyssa B Margolis, Tanya L Wallace, Lori Jean Van Orden, William J Martin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0232864
_version_ 1819110513706008576
author Elyssa B Margolis
Tanya L Wallace
Lori Jean Van Orden
William J Martin
author_facet Elyssa B Margolis
Tanya L Wallace
Lori Jean Van Orden
William J Martin
author_sort Elyssa B Margolis
collection DOAJ
description Activation of the kappa opioid receptor (KOR) contributes to the aversive properties of stress, and modulates key neuronal circuits underlying many neurobehavioral disorders. KOR agonists directly inhibit ventral tegmental area (VTA) dopaminergic neurons, contributing to aversive responses (Margolis et al. 2003, 2006); therefore, selective KOR antagonists represent a novel therapeutic approach to restore circuit function. We used whole cell electrophysiology in acute rat midbrain slices to evaluate pharmacological properties of four novel KOR antagonists: BTRX-335140, BTRX-395750, PF-04455242, and JNJ-67953964. Each compound concentration-dependently reduced the outward current induced by the KOR selective agonist U-69,593. BTRX-335140 and BTRX-395750 fully blocked U-69,593 currents (IC50 = 1.2 ± 0.9 and 1.2 ± 1.3 nM, respectively). JNJ-67953964 showed an IC50 of 3.0 ± 4.6 nM. PF-04455242 exhibited partial antagonist activity asymptoting at 55% blockade (IC50 = 6.7 ± 15.1 nM). In 3/8 of neurons, 1 μM PF-04455242 generated an outward current independent of KOR activation. BTRX-335140 (10 nM) did not affect responses to saturating concentrations of the mu opioid receptor (MOR) agonist DAMGO or the delta opioid receptor (DOR) agonist DPDPE, while JNJ-67953964 (10 nM) partially blocked DAMGO and DPDPE responses. Importantly, BTRX-335140 (10 nM) rapidly washed out with complete recovery of U-69,593 responses within 10 min. Collectively, we show electrophysiological evidence of key differences amongst KOR antagonists that could impact their therapeutic potential and have not been observed using recombinant systems. The results of this study demonstrate the value of characterizing compounds in native neuronal tissue and within circuits implicated in the neurobehavioral disorders of interest.
first_indexed 2024-12-22T03:42:55Z
format Article
id doaj.art-454e71a72da340cc94fb1fd759cebbb9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T03:42:55Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-454e71a72da340cc94fb1fd759cebbb92022-12-21T18:40:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011512e023286410.1371/journal.pone.0232864Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.Elyssa B MargolisTanya L WallaceLori Jean Van OrdenWilliam J MartinActivation of the kappa opioid receptor (KOR) contributes to the aversive properties of stress, and modulates key neuronal circuits underlying many neurobehavioral disorders. KOR agonists directly inhibit ventral tegmental area (VTA) dopaminergic neurons, contributing to aversive responses (Margolis et al. 2003, 2006); therefore, selective KOR antagonists represent a novel therapeutic approach to restore circuit function. We used whole cell electrophysiology in acute rat midbrain slices to evaluate pharmacological properties of four novel KOR antagonists: BTRX-335140, BTRX-395750, PF-04455242, and JNJ-67953964. Each compound concentration-dependently reduced the outward current induced by the KOR selective agonist U-69,593. BTRX-335140 and BTRX-395750 fully blocked U-69,593 currents (IC50 = 1.2 ± 0.9 and 1.2 ± 1.3 nM, respectively). JNJ-67953964 showed an IC50 of 3.0 ± 4.6 nM. PF-04455242 exhibited partial antagonist activity asymptoting at 55% blockade (IC50 = 6.7 ± 15.1 nM). In 3/8 of neurons, 1 μM PF-04455242 generated an outward current independent of KOR activation. BTRX-335140 (10 nM) did not affect responses to saturating concentrations of the mu opioid receptor (MOR) agonist DAMGO or the delta opioid receptor (DOR) agonist DPDPE, while JNJ-67953964 (10 nM) partially blocked DAMGO and DPDPE responses. Importantly, BTRX-335140 (10 nM) rapidly washed out with complete recovery of U-69,593 responses within 10 min. Collectively, we show electrophysiological evidence of key differences amongst KOR antagonists that could impact their therapeutic potential and have not been observed using recombinant systems. The results of this study demonstrate the value of characterizing compounds in native neuronal tissue and within circuits implicated in the neurobehavioral disorders of interest.https://doi.org/10.1371/journal.pone.0232864
spellingShingle Elyssa B Margolis
Tanya L Wallace
Lori Jean Van Orden
William J Martin
Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
PLoS ONE
title Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
title_full Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
title_fullStr Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
title_full_unstemmed Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
title_short Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
title_sort differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology
url https://doi.org/10.1371/journal.pone.0232864
work_keys_str_mv AT elyssabmargolis differentialeffectsofnovelkappaopioidreceptorantagonistsondopamineneuronsusingacutebrainsliceelectrophysiology
AT tanyalwallace differentialeffectsofnovelkappaopioidreceptorantagonistsondopamineneuronsusingacutebrainsliceelectrophysiology
AT lorijeanvanorden differentialeffectsofnovelkappaopioidreceptorantagonistsondopamineneuronsusingacutebrainsliceelectrophysiology
AT williamjmartin differentialeffectsofnovelkappaopioidreceptorantagonistsondopamineneuronsusingacutebrainsliceelectrophysiology